Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


14.01.2019

1 Blood
1 Br J Dermatol
3 Br J Haematol
1 Cancer
1 Haematologica
2 J Clin Oncol
2 Lancet Oncol
2 Leuk Lymphoma
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Blood

  1. GRANDE BM, Gerhard DS, Jiang A, Griner NB, et al
    Genome-wide discovery of somatic coding and non-coding mutations in pediatric endemic and sporadic Burkitt lymphoma.
    Blood. 2019 Jan 7. pii: blood-2018-09-871418. doi: 10.1182/blood-2018-09-871418.
    PubMed     Text format     Abstract available


    Br J Dermatol

  2. ENZAN N, Kitadate A, Tanaka A, Matsue K, et al
    Incisional random skin biopsy, not punch biopsy, is an appropriate method for diagnosis of intravascular large B-cell lymphoma: A clinicopathological study of 25 patients.
    Br J Dermatol. 2019 Jan 4. doi: 10.1111/bjd.17603.
    PubMed     Text format     Abstract available


    Br J Haematol

  3. BATALLER A, Combalia A, Garcia-Herrera A, Estrach T, et al
    Isolated cutaneous lymphomatous form of adult T-cell leukaemia/lymphoma.
    Br J Haematol. 2019 Jan 6. doi: 10.1111/bjh.15744.
    PubMed     Text format    

  4. CHU Y, Gardenswartz A, Termuhlen AM, Cairo MS, et al
    Advances in cellular and humoral immunotherapy - implications for the treatment of poor risk childhood, adolescent, and young adult B-cell non-Hodgkin lymphoma.
    Br J Haematol. 2019 Jan 6. doi: 10.1111/bjh.15753.
    PubMed     Text format     Abstract available

  5. CWYNARSKI K, Marzolini MAV, Barrington SF, Follows G, et al
    The management of primary mediastinal B-cell lymphoma: a British Society for Haematology Good Practice Paper.
    Br J Haematol. 2019 Jan 4. doi: 10.1111/bjh.15731.
    PubMed     Text format    


    Cancer

  6. HAHN EE, Wu YL, Munoz-Plaza CE, Garcia Delgadillo J, et al
    Use of recommended posttreatment services for adolescent and young adult survivors of Hodgkin lymphoma.
    Cancer. 2019 Jan 8. doi: 10.1002/cncr.31953.
    PubMed     Text format     Abstract available


    Haematologica

  7. SILVA A, Bassim S, Sarkozy C, Mottok A, et al
    Convergence of risk prediction models in follicular lymphoma.
    Haematologica. 2019 Jan 3. pii: haematol.2018.209031.
    PubMed     Text format    


    J Clin Oncol

  8. GERSON JN, Handorf E, Villa D, Gerrie AS, et al
    Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era.
    J Clin Oncol. 2019 Jan 7:JCO1800690. doi: 10.1200/JCO.18.00690.
    PubMed     Text format     Abstract available

  9. ANSELL SM, Minnema MC, Johnson P, Timmerman JM, et al
    Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study.
    J Clin Oncol. 2019 Jan 8:JCO1800766. doi: 10.1200/JCO.18.00766.
    PubMed     Text format     Abstract available


    Lancet Oncol

  10. TROTMAN J, Barrington SF, Meignan M
    Does end-of-treatment FDG-PET improve outcomes in follicular lymphoma? - Authors' reply.
    Lancet Oncol. 2019;20:e5.
    PubMed     Text format    

  11. ADAMS HJA, Kwee TC
    Does end-of-treatment FDG-PET improve outcomes in follicular lymphoma?
    Lancet Oncol. 2019;20:e4.
    PubMed     Text format    


    Leuk Lymphoma

  12. AL-MANSOUR Z, Li H, Cook JR, Constine LS, et al
    Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis.
    Leuk Lymphoma. 2019 Jan 10:1-8. doi: 10.1080/10428194.2018.1563691.
    PubMed     Text format     Abstract available

  13. MARECKOVA A, Malcikova J, Tom N, Pal K, et al
    ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.
    Leuk Lymphoma. 2019 Jan 10:1-9. doi: 10.1080/10428194.2018.1542144.
    PubMed     Text format     Abstract available


    PLoS One

  14. GUO B, Tan X, Ke Q, Cen H, et al
    Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis.
    PLoS One. 2019;14:e0210224.
    PubMed     Text format     Abstract available

  15. TAKASHIMA Y, Kawaguchi A, Iwadate Y, Hondoh H, et al
    MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
    PLoS One. 2019;14:e0210400.
    PubMed     Text format     Abstract available

  16. ANNIBALI O, Piccioni L, Tomarchio V, Circhetta E, et al
    Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients.
    PLoS One. 2018;13:e0200221.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: